Search

Your search keyword '"Buchrieser, Julian"' showing total 152 results

Search Constraints

Start Over You searched for: Author "Buchrieser, Julian" Remove constraint Author: "Buchrieser, Julian"
152 results on '"Buchrieser, Julian"'

Search Results

1. Pregnancy complications and Interferon-induced transmembrane proteins (IFITM): balancing antiviral immunity and placental development

3. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion

4. TMPRSS2 is a functional receptor for human coronavirus HKU1

7. Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

8. Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2

9. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

11. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

12. Understanding human mononuclear phagocyte ontogeny using human induced pluripotent stem cells (iPSCs)

13. Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus

14. High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

19. Syncytia formation by SARS‐CoV‐2‐infected cells

20. 9:10-9:30 IFN, TORCH, IFITM & pregnancy

23. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies

24. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants

26. Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells

28. Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2

29. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

30. Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization

32. SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation

33. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

34. Species-specific molecular barriers to SARS-CoV-2 replication in bat cells

35. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

36. Syncytia formation by SARS‐CoV‐2‐infected cells

38. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies

39. A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

40. Syncytia formation by SARS-CoV-2 infected cells

41. SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells

42. SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors

43. Anti‐ HIV ‐1 antibodies trigger non‐lytic complement deposition on infected cells

44. Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication

46. The Atlastin ER-shaping proteins facilitate Zika virus replication

47. IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise

48. RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation

49. A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response

50. A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response

Catalog

Books, media, physical & digital resources